Oramed Pharmaceuticals Inc. (TLV:ORMP)
725.00
-12.10 (-1.64%)
Jul 31, 2025, 5:24 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 298.31 million as of August 1, 2025. Its market cap has decreased by -20.75% in one year.
Market Cap
298.31M
Enterprise Value
-147.58M
Revenue
7.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
725.00
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 298.31M, an increase of 12,480.07%. That is a compound annual growth rate of 25.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 298.31M | -16.04% |
Dec 31, 2024 | 355.33M | 5.88% |
Dec 29, 2023 | 335.58M | -79.72% |
Dec 30, 2022 | 1.65B | -2.19% |
Dec 31, 2021 | 1.69B | 376.42% |
Dec 31, 2020 | 355.06M | 14.73% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 65.21B |
Danel (Adir Yeoshua) | 2.78B |
Kamada | 1.47B |
Bait Bakfar | 1.13B |
SofWave Medical | 879.72M |
BrainsWay | 756.69M |
Novolog (Pharm-Up 1966) | 710.12M |
Ilex Medical | 675.20M |